Concepedia

Katty Zeven

KZ

5

Publications

114

Citations

5

H-Index

2019

Active since

Affiliations

Vrije Universiteit Brussel(Current)

Universitair Ziekenhuis Brussel

VIB-UGent Center for Inflammation Research

Vlaams Instituut voor Biotechnologie

Katty Zeven is an author at Vrije Universiteit Brussel specializing in cancer therapeutics, biomedical engineering, and nanoparticles.

ORCID

Top concepts

Publications per year

2019–2024

5

Publications

5

Noninvasive Imaging of the Immune Checkpoint LAG-3 Using Nanobodies, from Development to Pre-Clinical Use

Quentin Lecocq, Katty Zeven, Yannick De Vlaeminck et al. · Biomolecules · 2019 · 53 citations · Full text

Emerging applications of nanobodies in cancer therapy

Robin Maximilian Awad, Fien Meeus, Hannelore Ceuppens et al. · International review of cell and molecular biology · 2022 · 20 citations · Full text

, , +4

Development and evaluation of nanobody tracers for noninvasive nuclear imaging of the immune-checkpoint TIGIT

Katty Zeven, Timo W.M. De Groof, Hannelore Ceuppens et al. · Frontiers in Immunology · 2023 · 15 citations · Full text

Formatting and gene-based delivery of a human PD-L1 single domain antibody for immune checkpoint blockade

Robin Maximilian Awad, Quentin Lecocq, Katty Zeven et al. · Molecular Therapy — Methods & Clinical Development · 2021 · 14 citations · Full text

Preclinical evaluation of antigen-sensitive B7-H3-targeting nanobody-based CAR-T cells in glioblastoma cautions for on-target, off-tumor toxicity

Fien Meeus, Cyprine Neba Funeh, Robin Maximilian Awad et al. · Journal for ImmunoTherapy of Cancer · 2024 · 12 citations · Full text

Rows per page

1–5 of 5